Colon News and Research

RSS

Newly established Precision Immunotherapy Clinic matches cancer patients to latest treatments

A third occurrence of colon cancer and a failed immunotherapy clinical trial left Gordon Levine confined to a wheelchair with large tumors in his right hip bone, spine and lung, plus smaller tumors throughout his body, including one that caused an obstruction in his colon.

17 Oct 2019

New guidance from oncology experts recommends tailored exercise prescriptions

New guidance from exercise oncology experts recommend systematic use of an "exercise prescription" by health care workers and fitness professionals in designing and delivering exercise programs that aim to lower the risk of developing certain cancers and best meet the needs, preferences and abilities of people with cancer.

17 Oct 2019

Study represents a major step in seeking alternative cancer treatments for non-responders

Research led by VHIO's Alena Gros signposts a new, less invasive approach to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to approved immune-based treatments.

16 Oct 2019

Hyperbaric oxygen therapy can relieve symptoms and side-effects of radiotherapy

Hyperbaric oxygen therapy can relieve self-reported symptoms and side-effects of radiotherapy against cancer in the pelvic region, a study shows. After 30-40 sessions in a hyperbaric chamber, many patients experienced reductions in bleeding, urinary incontinence, and pain alike.

16 Oct 2019

New recommendations outline specific 'exercise prescriptions' for cancer survivors

A recent review of research, conducted by an international group of experts led by the University of British Columbia, has resulted in the development of new exercise guidelines for cancer survivors.

16 Oct 2019

Researchers outline new exercise recommendations for people living with and beyond cancer

It's well known that exercise is good for preventing and treating many forms of heart disease, but less commonly known are the benefits of physical activity for people living with and beyond cancer.

16 Oct 2019

Good news for IBS sufferers as researchers identify “gut itch”

Researchers have identified receptors that cause the pain experienced in cases of irritable bowel syndrome.

16 Oct 2019

New guidance recommends systematic use of 'exercise prescription' for cancer patients

A global panel of exercise oncology experts today published new guidance recommending the systematic use of an “exercise prescription” to help cancer patients cope with treatment side effects and lower the risk of developing certain cancers.

15 Oct 2019

Being overweight before 40 raises the risk of cancer

Obesity has been proven to be a major risk factor for several cancers. Weight gain during adulthood has been tied to increased cancer risk, but there is a little body of knowledge that has identified accurate timing and duration of weight gain.

14 Oct 2019

Overweight before age 40 linked to increased cancer risk

In an international study, lead by the University of Bergen in Norway, the researchers wanted to find out how adult overweight (BMI over 25) and obesity (BMI over 30) increase the risk of different types of cancer.

11 Oct 2019

Survey provides clear of picture of how Americans are embracing healthy living

Who are Americans more likely to take health advice from…their doctors or an Instagram influencer? Would U.S. adults rather talk or text? Socialize in real life or scroll through social media? Parade magazine and Cleveland Clinic joined forces for the second year in a row to poll Americans on their adoption of health, lifestyle, fitness and diet trends and takes a look at how social media has helped move health practices that once seemed extreme into the mainstream.

11 Oct 2019

Study may lead the way to decrease DLBCL relapse, development of second primary cancer

With improved treatments, especially the use of anti-cancer immunotherapies, more than two-thirds of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) will survive. However, after treatment, patients are at a small but real risk of developing a new cancer, called a second primary cancer.

8 Oct 2019

Cincinnati Children's receives NIH grant renewal for collaborative research into eosinophilic disorders

Cincinnati Children's Hospital Medical Center has received a 5-year, $7.57 million grant renewal from the National Institutes of Health to continue leading a consortium of organizations from around the country that will conduct clinical research into eosinophilic gastrointestinal disorders.

7 Oct 2019

Researchers determine how the colon prioritizes gas detox over energy use

Onions, cabbage, garlic. While nutritious, eating these foods can lead to an embarrassing side effect: smelly flatulence. More than just smelly, hydrogen sulfide, the chemical compound responsible for the rotten-egg aroma, is deadly if inhaled at doses of more than 700 parts per million.

7 Oct 2019

GW researchers show connection between bacteria in the microbiome and colon cancer

A mutant protein found in humans with colon cancer blocks a pathway that regulates proliferation and expansion of cells, increasing amounts of bacterial species associated with the development of colon cancer.

4 Oct 2019

UC Davis researchers awarded $1.5 million NIH grant for CRISPR cancer treatment

What if, instead of killing cancer cells or cells about to become cancerous, you could deliver a repair package and fix them? UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health to start work towards that goal.

3 Oct 2019

Reducing the amount red and processed meat can have a positive effect on health

A new study has found that halving the amount red and processed meat in the diet can have a significant impact on health, reducing the amount of LDL 'bad' cholesterol in the blood which cuts the risk of developing heart disease.

30 Sep 2019

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

Results presented today at the ESMO Congress 2019, Barcelona 27 September - 01 October, during the second Proffered Paper Session on Gastrointestinal tumors (colorectal) by VHIO's Director, Josep Tabernero, show that the triplet combination of the BRAF inhibitor, encorafenib, MEK inhibitor, binimetinib, and EGFR inhibitor, cetuximab, not only significantly improves overall survival but also increases objective response rates compared with standard of care in patients with BRAF V600E-mutant metastatic colorectal cancer.

30 Sep 2019

New trial shows improved survival for patients with advanced colorectal BRAF-mutant cancer

A clinical trial has shown that using a combination of three drugs that target a BRAF gene mutation in patients with mCRC effectively boosts overall survival.

30 Sep 2019

Study: Three-drug combination improves overall survival in patients with mCRC

The three-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival (OS) in patients with BRAF-mutated metastatic colorectal cancer (mCRC), according to results of the BEACON CRC Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.

30 Sep 2019

Colon News and Research

Newly established Precision Immunotherapy Clinic matches cancer patients to latest treatments

New guidance from oncology experts recommends tailored exercise prescriptions

Study represents a major step in seeking alternative cancer treatments for non-responders

Hyperbaric oxygen therapy can relieve symptoms and side-effects of radiotherapy

New recommendations outline specific 'exercise prescriptions' for cancer survivors

Researchers outline new exercise recommendations for people living with and beyond cancer

Good news for IBS sufferers as researchers identify “gut itch”

New guidance recommends systematic use of 'exercise prescription' for cancer patients

Being overweight before 40 raises the risk of cancer

Overweight before age 40 linked to increased cancer risk

Survey provides clear of picture of how Americans are embracing healthy living

Study may lead the way to decrease DLBCL relapse, development of second primary cancer

Cincinnati Children's receives NIH grant renewal for collaborative research into eosinophilic disorders

Researchers determine how the colon prioritizes gas detox over energy use

GW researchers show connection between bacteria in the microbiome and colon cancer

UC Davis researchers awarded $1.5 million NIH grant for CRISPR cancer treatment

Reducing the amount red and processed meat can have a positive effect on health

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

New trial shows improved survival for patients with advanced colorectal BRAF-mutant cancer

Study: Three-drug combination improves overall survival in patients with mCRC

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News